COMSTOCK RESOURCES INC (CRK)

US2057683029 - Common Stock

19.05  +1.96 (+11.47%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CRK. CRK was compared to 205 industry peers in the Oil, Gas & Consumable Fuels industry. CRK may be in some trouble as it scores bad on both profitability and health. CRK is valied quite expensively at the moment, while it does show a decent growth rate.



2

1. Profitability

1.1 Basic Checks

CRK had negative earnings in the past year.
CRK had a positive operating cash flow in the past year.
In multiple years CRK reported negative net income over the last 5 years.
In the past 5 years CRK always reported a positive cash flow from operatings.

1.2 Ratios

The Return On Assets of CRK (-1.01%) is worse than 77.94% of its industry peers.
CRK has a Return On Equity of -2.77%. This is in the lower half of the industry: CRK underperforms 75.49% of its industry peers.
Industry RankSector Rank
ROA -1.01%
ROE -2.77%
ROIC N/A
ROA(3y)5.84%
ROA(5y)3.46%
ROE(3y)12.11%
ROE(5y)7.08%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

In the last couple of years the Operating Margin of CRK has declined.
CRK's Gross Margin of 53.90% is in line compared to the rest of the industry. CRK outperforms 59.31% of its industry peers.
CRK's Gross Margin has declined in the last couple of years.
CRK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.9%
OM growth 3Y-8.67%
OM growth 5Y-19.01%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.8%
GM growth 5Y-6.83%

0

2. Health

2.1 Basic Checks

CRK does not have a ROIC to compare to the WACC, probably because it is not profitable.
CRK has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CRK has more shares outstanding
The debt/assets ratio for CRK is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 1.03, we must say that CRK is in the distress zone and has some risk of bankruptcy.
CRK has a Altman-Z score of 1.03. This is in the lower half of the industry: CRK underperforms 60.78% of its industry peers.
A Debt/Equity ratio of 1.28 is on the high side and indicates that CRK has dependencies on debt financing.
CRK has a worse Debt to Equity ratio (1.28) than 77.45% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.28
Debt/FCF N/A
Altman-Z 1.03
ROIC/WACCN/A
WACC8.68%

2.3 Liquidity

CRK has a Current Ratio of 0.60. This is a bad value and indicates that CRK is not financially healthy enough and could expect problems in meeting its short term obligations.
CRK has a Current ratio of 0.60. This is amonst the worse of the industry: CRK underperforms 82.35% of its industry peers.
A Quick Ratio of 0.60 indicates that CRK may have some problems paying its short term obligations.
CRK has a Quick ratio of 0.60. This is in the lower half of the industry: CRK underperforms 77.94% of its industry peers.
Industry RankSector Rank
Current Ratio 0.6
Quick Ratio 0.6

5

3. Growth

3.1 Past

CRK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -121.13%.
The Earnings Per Share has been growing by 18.84% on average over the past years. This is quite good.
The Revenue for CRK has decreased by -49.44% in the past year. This is quite bad
CRK shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 32.02% yearly.
EPS 1Y (TTM)-121.13%
EPS 3Y18.84%
EPS 5YN/A
EPS Q2Q%-525%
Revenue 1Y (TTM)-49.44%
Revenue growth 3Y22.18%
Revenue growth 5Y32.02%
Sales Q2Q%-19.18%

3.2 Future

The Earnings Per Share is expected to grow by 71.48% on average over the next years. This is a very strong growth
Based on estimates for the next years, CRK will show a small growth in Revenue. The Revenue will grow by 7.34% on average per year.
EPS Next Y-180.71%
EPS Next 2Y-5.15%
EPS Next 3Y24%
EPS Next 5Y71.48%
Revenue Next Year-15.5%
Revenue Next 2Y5.77%
Revenue Next 3Y7.34%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

CRK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 45.06, the valuation of CRK can be described as expensive.
Based on the Price/Forward Earnings ratio, CRK is valued a bit more expensive than 71.57% of the companies in the same industry.
CRK's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.86.
Industry RankSector Rank
PE N/A
Fwd PE 45.06

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CRK is valued a bit more expensive than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 11.98

4.3 Compensation for Growth

A more expensive valuation may be justified as CRK's earnings are expected to grow with 24.00% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-5.15%
EPS Next 3Y24%

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.00%, CRK has a reasonable but not impressive dividend return.
CRK's Dividend Yield is comparable with the industry average which is at 6.96.
Compared to an average S&P500 Dividend Yield of 2.30, CRK pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3%

5.2 History

CRK has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1

5.3 Sustainability

CRK has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-54.83%
EPS Next 2Y-5.15%
EPS Next 3Y24%

COMSTOCK RESOURCES INC

NYSE:CRK (12/30/2024, 12:55:09 PM)

19.05

+1.96 (+11.47%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)10-30 2024-10-30/amc
Earnings (Next)02-11 2025-02-11/amc
Inst Owners35.07%
Inst Owner Change-6.87%
Ins Owners2.04%
Ins Owner Change6.13%
Market Cap5.57B
Analysts51.43
Price Target11.77 (-38.22%)
Short Float %33.89%
Short Ratio12.05
Dividend
Industry RankSector Rank
Dividend Yield 3%
Dividend Growth(5Y)N/A
DP-54.83%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-13.59%
Min EPS beat(2)-22.17%
Max EPS beat(2)-5.01%
EPS beat(4)1
Avg EPS beat(4)2.41%
Min EPS beat(4)-22.17%
Max EPS beat(4)58.16%
EPS beat(8)2
Avg EPS beat(8)-11%
EPS beat(12)4
Avg EPS beat(12)-8.68%
EPS beat(16)7
Avg EPS beat(16)3.3%
Revenue beat(2)0
Avg Revenue beat(2)-12.22%
Min Revenue beat(2)-17.72%
Max Revenue beat(2)-6.71%
Revenue beat(4)1
Avg Revenue beat(4)-6.42%
Min Revenue beat(4)-17.72%
Max Revenue beat(4)2.28%
Revenue beat(8)4
Avg Revenue beat(8)2.07%
Revenue beat(12)8
Avg Revenue beat(12)24.49%
Revenue beat(16)12
Avg Revenue beat(16)21.29%
PT rev (1m)13.06%
PT rev (3m)22.08%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-80.16%
EPS NY rev (1m)-1.45%
EPS NY rev (3m)-52.86%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-11.62%
Revenue NY rev (1m)-0.15%
Revenue NY rev (3m)-3.19%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 45.06
P/S 4.29
P/FCF N/A
P/OCF 9.57
P/B 2.43
P/tB 2.84
EV/EBITDA 11.98
EPS(TTM)-0.3
EYN/A
EPS(NY)0.42
Fwd EY2.22%
FCF(TTM)-1.96
FCFYN/A
OCF(TTM)1.99
OCFY10.44%
SpS4.44
BVpS7.85
TBVpS6.7
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.01%
ROE -2.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.9%
FCFM N/A
ROA(3y)5.84%
ROA(5y)3.46%
ROE(3y)12.11%
ROE(5y)7.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)25.53%
ROCE(5y)17.39%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-8.67%
OM growth 5Y-19.01%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.8%
GM growth 5Y-6.83%
F-Score3
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 1.28
Debt/FCF N/A
Debt/EBITDA 4.45
Cap/Depr 148.13%
Cap/Sales 88.9%
Interest Coverage N/A
Cash Conversion 87.83%
Profit Quality N/A
Current Ratio 0.6
Quick Ratio 0.6
Altman-Z 1.03
F-Score3
WACC8.68%
ROIC/WACCN/A
Cap/Depr(3y)199.81%
Cap/Depr(5y)179.54%
Cap/Sales(3y)52.58%
Cap/Sales(5y)56.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-121.13%
EPS 3Y18.84%
EPS 5YN/A
EPS Q2Q%-525%
EPS Next Y-180.71%
EPS Next 2Y-5.15%
EPS Next 3Y24%
EPS Next 5Y71.48%
Revenue 1Y (TTM)-49.44%
Revenue growth 3Y22.18%
Revenue growth 5Y32.02%
Sales Q2Q%-19.18%
Revenue Next Year-15.5%
Revenue Next 2Y5.77%
Revenue Next 3Y7.34%
Revenue Next 5YN/A
EBIT growth 1Y-113.89%
EBIT growth 3Y11.59%
EBIT growth 5Y6.92%
EBIT Next Year182.65%
EBIT Next 3Y66.24%
EBIT Next 5Y46.09%
FCF growth 1Y-215.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-59.76%
OCF growth 3Y20.88%
OCF growth 5Y40.16%